You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 014134


✉ Email this page to a colleague

« Back to Dashboard


NDA 014134 describes PROTOPAM CHLORIDE, which is a drug marketed by Baxter Hlthcare Corp and Wyeth Ayerst and is included in two NDAs. It is available from one supplier. Additional details are available on the PROTOPAM CHLORIDE profile page.

The generic ingredient in PROTOPAM CHLORIDE is pralidoxime chloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pralidoxime chloride profile page.
Summary for 014134
Tradename:PROTOPAM CHLORIDE
Applicant:Baxter Hlthcare Corp
Ingredient:pralidoxime chloride
Patents:0
Pharmacology for NDA: 014134
Mechanism of ActionCholinesterase Reactivators
Suppliers and Packaging for NDA: 014134
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROTOPAM CHLORIDE pralidoxime chloride INJECTABLE;INJECTION 014134 NDA Baxter Healthcare Corporation 60977-141 60977-141-01 6 VIAL, SINGLE-DOSE in 1 PACKAGE (60977-141-01) / 20 mL in 1 VIAL, SINGLE-DOSE (60977-141-27)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1GM/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.